Dimensional Fund Advisors
TERN

Dimensional Fund Advisors’s Terns Pharmaceuticals TERN Stock Holding History

Dimensional Fund Advisors’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65.8M Buy
1,247,845
+82
+0% +$3.37K 0.01% 1348
2025
Q4 		$50.4M Sell
1,247,763
-208,638
-14% -$4.82M 0.01% 1507
2025
Q3 		$10.9M Sell
1,456,401
-194,549
-12% -$1.24M ﹤0.01% 2271
2025
Q2 		$6.16M Sell
1,650,950
-55,251
-3% -$173K ﹤0.01% 2461
2025
Q1 		$4.71M Buy
1,706,201
+403,269
+31% +$1.65M ﹤0.01% 2510
2024
Q4 		$7.22M Buy
1,302,932
+673,570
+107% +$4.56M ﹤0.01% 2425
2024
Q3 		$5.25M Buy
629,362
+257,470
+69% +$2.12M ﹤0.01% 2510
2024
Q2 		$2.53M Buy
371,892
+31,875
+9% +$193K ﹤0.01% 2709
2024
Q1 		$2.23M Buy
340,017
+262,192
+337% +$1.71M ﹤0.01% 2768
2023
Q4 		$506K Sell
77,825
-10,887
-12% -$57.6K ﹤0.01% 3042
2023
Q3 		$446K Sell
88,712
-149,652
-63% -$950K ﹤0.01% 3065
2023
Q2 		$2.09M Buy
238,364
+1,253
+0.5% +$14.6K ﹤0.01% 2774
2023
Q1 		$2.81M Buy
237,111
+138,171
+140% +$1.32M ﹤0.01% 2651
2022
Q4 		$1.01K Buy
98,940
+65,628
+197% +$437K ﹤0.01% 2896
2022
Q3 		$196K Buy
+33,312
New +$124K ﹤0.01% 3241

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Dimensional Fund Advisors's TERN Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Terns Pharmaceuticals (TERN) stake by 0.01% in Q1 2026, buying an estimated $3.37K and bringing the position to 1,247,845 shares worth $65.8M. The position accounts for 0.01% of the portfolio, ranked #1348.

Dimensional Fund Advisors first reported a position in TERN in Q3 2022 and has held it in 15 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Dimensional Fund Advisors held 1,247,845 shares of Terns Pharmaceuticals worth $65.8M as of Q1 2026.
  • Dimensional Fund Advisors bought 82 Terns Pharmaceuticals shares in Q1 2026, an estimated $3.37K.
  • Terns Pharmaceuticals made up 0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1348 holding.
  • Dimensional Fund Advisors first reported a position in Terns Pharmaceuticals in Q3 2022 and has held it in 15 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.